- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hematologic Changes in New Zealand
Total 3032 results
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
University of Auckland, New ZealandAuckland District Health BoardUnknownPeritoneal Dessication Damage and Inflammation | Peri-operative HypothermiaNew Zealand
-
University of Auckland, New ZealandCounties Manukau HealthCompletedObesity, MorbidNew Zealand
-
University of Auckland, New ZealandUnknownCognitive Change | Learning Disabilities | Learning DisordersNew Zealand
-
Academy of Nutrition and DieteticsCompletedEnd Stage Renal Disease Requiring HemodialysisNew Zealand
-
University of SydneyUniversity of Roma La Sapienza; Australasian Bone Marrow Transplant Recipient... and other collaboratorsRecruiting
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...Completed
-
The Hospital for Sick ChildrenCompleted
-
Sight DiagnosticsCompleted
-
Naestved HospitalRegion Zealand; Denmark:Department of Otorhinolaryngology Slagelse Hospital...UnknownHypothyroidism | Goiter | Weight GainDenmark
-
Zealand University HospitalUnknownHematological CancerDenmark
-
NYU Langone HealthWithdrawnCancer | Hematological MalignancyUnited States
-
Smart Immune SASRecruitingHematological MalignanciesUnited States
-
Australia and New Zealand Intensive Care SocietyCompletedTraumatic Brain InjuryAustralia, New Zealand
-
Albert Einstein College of MedicineRecruiting
-
University of Auckland, New ZealandLeukaemia & Blood Cancer New ZealandActive, not recruiting
-
Orsenix LLCCompleted
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
AlexionAchillion, a wholly owned subsidiary of AlexionCompletedParoxysmal Nocturnal HemoglobinuriaNew Zealand, Korea, Republic of, Italy
-
Apellis Pharmaceuticals, Inc.CompletedParoxysmal Nocturnal HemoglobinuriaHong Kong, Thailand, New Zealand, Malaysia
-
Esanex Inc.Completed
-
Hangzhou Sumgen Biotech Co., Ltd.RecruitingSG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.Lymphoma | Hematological MalignancyUnited States
-
Prehospital Center, Region ZealandCompletedHypothermia Due to Cold Environment | Out-Of-Hospital Cardiac Arrest | Drowning | Hypothermia, AccidentalDenmark
-
Memorial Sloan Kettering Cancer CenterRecruitingFebrile Neutropenia | Intestinal MicrobiomeUnited States
-
Hospital for Special Surgery, New YorkRecruitingLumbar Spine Degenerative ChangesUnited States
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
HutchmedRecruitingIsocitrate Dehydrogenase Gene MutationSpain, United States
-
Kangpu Biopharmaceuticals, Ltd.RecruitingHematological MalignanciesUnited States
-
All India Institute of Medical Sciences, New DelhiTerminatedPediatric Cancer | Neutropenia, FebrileIndia
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
IncuronTerminatedHematological MalignanciesUnited States
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
Karyopharm Therapeutics IncCompletedHematological MalignanciesUnited States, Denmark, Canada
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Myeloma | Hematological MalignancyUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Leukemia | Myelodysplastic SyndromeUnited States
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of AlexionCompletedParoxysmal Nocturnal Hemoglobinuria (PNH)United Kingdom, New Zealand, Korea, Republic of, Italy
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicUnited States, Australia, New Zealand
-
TakedaAffymaxCompletedAnemiaUnited States, New Zealand, Australia, Italy, United Kingdom
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, Japan, Taiwan, Australia, Germany, China
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple MyelomaUnited States, New Zealand
-
Gilead SciencesTerminatedHematological MalignanciesUnited States, United Kingdom
-
Bausch & Lomb IncorporatedCompletedCorneal Endothelial Cell ChangesUnited States
-
Effector TherapeuticsTerminated
-
University Medical Center GroningenDutch Kidney Foundation; Innovation Fund of the Dutch Medical Insurance CompaniesCompletedMetabolic Syndrome | Kidney Transplant | Post-transplant Weight GainNetherlands
-
Matthew DallosBristol-Myers SquibbTerminatedSolid Tumor | Sars-CoV2 | Hematological MalignancyUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingHematological MalignanciesUnited States, Canada, Brazil, Chile, Denmark, France, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
Cerebos Pacific LimitedUnknown
-
PfizerTerminatedHealthy | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Primary Immune ThrombocytopeniaSpain, United States, Belgium, United Kingdom, New Zealand
-
Cardinal Tien HospitalCompleted